drugset / Trial / NCT00209456

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

NCT00209456 ↗

Phase 3 Completed 326 enrolled GE Healthcare
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The study is designed to determine the diagnostic efficacy of the visual assessment of SPECT scans in differentiating between probable dementia with Lewy Bodies (DLB) and non-DLB dementia subjects determined by the clinical diagnosis of an independent expert consensus panel used as the standard of truth.

Timeline

Start
2003-11
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ioflupane Unknown — —